Breast regimen-specific consent forms

Dear All,

 

I am pleased to inform you that the breast regimen-specific consent forms have been updated with the following:

  • Subcutaneous administration option for regimens containing Trastuzumab  and Pertuzumab.
  • Standard  statement on alcohol to regimens containing Gemcitabine and Paclitaxel.
  • Standard statement indicating the risk of diabetes with SACT treatment, including those where steroids are in the protocol for anti-emetic/allergy.

The forms are available via CRUK website at: www.cruk.org/sact_consent.

Please forward to your colleagues.

Any questions please let me know.

 

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Guy’s and St Thomas’ NHS Foundation Trust

Guy’s Hospital | Great Maze Pond | London | SE1 9RT
SACT regimen-specific consent forms: www.cruk.org/sact consent |

Our values: Put patients first | Take pride in what we do | Respect others | Strive to be the best | Act with integrity

 

Latest News

By BOPA on 13th March 2026

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article
By BOPA Education & Training Subcommittee on 9th March 2026

Webinar Cancelled: AI Implementation: Taking a chemotherapy risk prediction AI model from research into industry and practice

Dear BOPA members Due to unforeseen circumstances tomorrow’s webinar AI Implementation: Taking a chemotherapy risk prediction AI model from research into industry and practice (10th March 2026) had to be cancelled. Will…

Read article
By BOPA Digital SACT Verification Passport Team on 9th March 2026

BOPA SACT Passport: Reminder to ALL Super-managers, Managers and Assessors

Dear BOPA Members and Digital SACT Verification Passport Users This is a reminder to all super-managers, managers and assessors of the BOPA SACT Passport to: – Ensure all staff within your Passport…

Read article
By BOPA Research Subcommittee on 9th March 2026

Abstract Submission for #BOPA2026 opens 30th March 2026

Abstract Submission for the 29th Annual BOPA Conference 2026 opens on 30th March 2026     Delegates are invited to present results of their clinical and technical work as a…

Read article